Abstract
Paul Stoffels, Johnson & Johnson’s chief scientific officer, will retire at the end of the year. Stoffels is credited with leading the development of J&J’s COVID-19 vaccine, as well as vaccines and treatments for HIV, Ebola, and tuberculosis. He also spearheaded Johnson & Johnson Innovation, a program to identify and incubate promising technologies and treatments. J&J has not announced Stoffels’s successor.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
